These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19465103)

  • 1. Pharmaceutical quality evaluation of lipid emulsions containing PGE1: alteration in the number of large particles in infusion solutions.
    Shibata H; Saito H; Yomota C; Kawanishi T
    Int J Pharm; 2009 Aug; 378(1-2):167-76. PubMed ID: 19465103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of release and retentivity of prostaglandin E1 in lipid emulsion.
    Yamaguchi T; Fukushima Y; Itai S; Hayashi H
    Biochim Biophys Acta; 1995 Jun; 1256(3):381-6. PubMed ID: 7786903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of therapeutic efficacy of lipid microspheres incorporating prostaglandin E1 by mixing with aqueous solution.
    Komori Y; Aiba T; Kushima M; Kawasaki H; Kurosaki Y
    J Pharm Sci; 2007 Apr; 96(4):935-43. PubMed ID: 17238198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat emulsion particle-size distribution in total nutrient admixtures.
    Mehta RC; Head LF; Hazrati AM; Parr M; Rapp RP; DeLuca PP
    Am J Hosp Pharm; 1992 Nov; 49(11):2749-55. PubMed ID: 1471641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term stability of lipid emulsions with parenteral nutrition solutions.
    Tannuri U; Sesso A; Coelho MC; Maksoud JG
    Nutrition; 1992; 8(2):98-100. PubMed ID: 1591460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between non-ionic contrast medium and prostaglandin E1 incorporated in lipid microspheres: in-vitro comparative study of direct and non-direct mixing.
    Hayashi H; Uchiyama N; Kawamata H; Takagi R; Abe Y; Kumazaki T
    Radiat Med; 2000; 18(4):219-25. PubMed ID: 11246996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation optimization of prostaglandin E₁-loaded lipid emulsion: enhanced stability and reduced biodegradation.
    Zhang N; Zhang Q; Chu T; Jin H; Ma WC; Fu HM; Yu XY; Li Q; Wang ZZ; Mao SJ
    Pharm Dev Technol; 2013; 18(4):804-12. PubMed ID: 22335624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Container effects on the physicochemical properties of parenteral lipid emulsions.
    Gonyon T; Carter PW; Dahlem O; Denet AR; Owen H; Trouilly JL
    Nutrition; 2008; 24(11-12):1182-8. PubMed ID: 18707847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the coalescence kinetics of fat emulsions in dependence on the amount of fat and age.
    Harnisch S; Schuhmann R; Harnisch JF; Müller RH
    Pharmazie; 2002 Jan; 57(1):54-8. PubMed ID: 11836933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parenteral nutrition: stability of lipid emulsions in different preparations].
    Klaassen JA; Maiz A; Toro M; Acosta AM
    Rev Med Chil; 1989 Nov; 117(11):1227-31. PubMed ID: 2519796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration.
    de Lemos ML; Monfared S; Denyssevych T; Hamata L; Jennings S; Thiessen B; Smith S; Waterhouse D
    J Oncol Pharm Pract; 2009 Mar; 15(1):45-52. PubMed ID: 18772215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [General characteristics and problems of the galenic aspects of fat emulsions].
    Kleinberger G; Pamperl H
    Infusionsther Klin Ernahr; 1983 Jun; 10(3):108-17. PubMed ID: 6350174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The physical compatibility of ketamine and diazepam in infusion solutions].
    Lechner MD; Kreuscher H
    Anaesthesist; 1989 Aug; 38(8):418-20. PubMed ID: 2782599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical stability of lipid injectable emulsions: correlating changes in large globule distributions with phase separation behavior.
    Gonyon T; Patel P; Owen H; Dunham AJ; Carter PW
    Int J Pharm; 2007 Oct; 343(1-2):208-19. PubMed ID: 17618071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations on prevention of phlebitis and venous pain from intravenous prostaglandin E(1) administration by adjusting solution pH: in vitro manipulations affecting pH.
    Kohno E; Nishikata M; Okamura N; Matsuyama K
    Yakugaku Zasshi; 2008 Jan; 128(1):111-5. PubMed ID: 18176061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of intravenous administration of lipo-prostaglandin E1 on the ischemic gastric tube in pigs.
    Tobari S; Ikeda Y; Takami H
    J Surg Res; 2005 Nov; 129(1):79-84. PubMed ID: 16087193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine vs. coarse complete all-in-one admixture infusions over 96 hours in rats: fat globule size and hepatic function.
    Driscoll DF; Ling PR; Silvestri AP; Bistrian BR
    Clin Nutr; 2008 Dec; 27(6):889-94. PubMed ID: 18849096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility of drug infusions in the NICU.
    Kalikstad B; Skjerdal A; Hansen TW
    Arch Dis Child; 2010 Sep; 95(9):745-8. PubMed ID: 20570841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacopeial evolution of intralipid injectable emulsion in plastic containers: from a coarse to a fine dispersion.
    Driscoll DF
    Int J Pharm; 2009 Feb; 368(1-2):193-8. PubMed ID: 18996455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.